Company
kalderos
Kalderos created the world’s first Drug Discount Management platform
Also known as Kalderos, Inc.
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Chicago, IL, United States
- Founded
- 2016
- Customers
- life science businesses
- Legal name
- Kalderos, Inc.
- kalderos.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Kalderos created the first platform for Drug Discount Management, leveraging an unprecedented amount of drug discount data and providing unprecedented clarity to every stakeholder.
Funding snapshot
- Total raised
- $76.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series B, $28M2020
Funding rounds
- Round, 2024
- $26.4M2024-12-20, SEC form D sold, 8 investors
- Round, 2022
- $14.9M2022-08-26, SEC form D sold, 9 investors
- Round, 2020
- $28M2020-05-26, SEC form D sold, 6 investors
- Series B
- $28M2020, Company stated
- Round, 2019
- $7M2019-04-26, SEC form D sold, 2 investors
- Series A
- $7M2019, Company stated
About the company
- Status notes
- Kalderos has been acquired by Model N, the leading end-to-end commercialization, optimization, and compliance platform for life sciences companies.
Products
- Web
- Commercial Discount Monitoring
- Web
- Discount Hub
- Web
- MDRP Discount Monitoring
- Web
- Truzo
Loading relationship preview